Literature DB >> 24228826

Herpes simplex virus encephalitis during treatment with etanercept.

Robbert H J Crusio1, Stephanie V Singson, Faysal Haroun, Hetal H Mehta, David M Parenti.   

Abstract

Tumor necrosis factor alpha (TNF-α) inhibitors are widely used for the treatment of various inflammatory conditions. They are associated with an increased risk for infections. We report a case of herpes simplex virus type 1 (HSV-1) encephalitis in a patient receiving etanercept and review the literature on TNF-α and TNF-α inhibitors, and their importance in the pathophysiology of herpes simplex encephalitis.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24228826     DOI: 10.3109/00365548.2013.849816

Source DB:  PubMed          Journal:  Scand J Infect Dis        ISSN: 0036-5548


  4 in total

1.  Herpes Encephalitis: A Mortal Complication in a Patient Treated with Immunosuppressive Drugs because of Immune-Related Adverse Events after Ipilimumab Treatment.

Authors:  Lieke van Montfort; Caroline M Loos; Monique Anten; Rob L H Jansen
Journal:  Case Rep Oncol       Date:  2017-12-18

Review 2.  Immunomodulatory Strategies in Herpes Simplex Virus Encephalitis.

Authors:  Jocelyne Piret; Guy Boivin
Journal:  Clin Microbiol Rev       Date:  2020-02-12       Impact factor: 26.132

Review 3.  Herpes Simplex Encephalitis: an Update.

Authors:  John W Gnann; Richard J Whitley
Journal:  Curr Infect Dis Rep       Date:  2017-03       Impact factor: 3.725

4.  Anti-inflammatory effects of recombinant human PDCD5 (rhPDCD5) in a rat collagen-induced model of arthritis.

Authors:  Juan Xiao; Ge Li; Jia Hu; Liujing Qu; Dalong Ma; Yingyu Chen
Journal:  Inflammation       Date:  2015-02       Impact factor: 4.092

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.